HS
Henry Skinner
Chief Executive Officer at AMR Action Fund
Houston, Texas
Overview
Henry Skinner is the Chief Executive Officer at AMR Action Fund, with a background in business development, management, and the pharmaceutical industry. Highlights of his career include serving as Senior Vice President at Tekla Capital Management LLC and Managing Director at Novartis Venture Funds, showcasing his expertise in venture capital and strategic alliances within the life sciences sector.
Work Experience
Chief Executive Officer
2021 - Current
AMR Action Fund renders investment, healthcare, biotech, research and development, pharmaceutical, and antibiotic services.
Senior Vice President, Venture
2017 - 2021
Managing Director Novartis Venture Funds
2008 - 2017
Executive Director
2006 - 2008
Head Strategic Alliances, Therapeutics
2006 - 2008
Executive Director and Head Strategic Alliances, Therapeutics
2006 - 2008
Chief Executive Officer
2005 - 2006
Consultant
2004 - 2006
President and Chief Executive Officer
2003 - 2005
Senior Director
1999 - 2003
Director Technology Acquisitions
1997 - 2002
Director Technology Acquisitions
1997 - 2001
Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.
Raised $32,000,000,000.00 from Starboard Value.
Director Business Development
1995 - 1997